Découvrez comment MaaT Pharma restaure les fonctions du Microbiote Intestinal de patients traités par Chimiothérapie et…
mrossettiNovember 29, 2018
Lyon, France, November 2, 2018 – MaaT Pharma announced today that the company will present…
MaaT PharmaNovember 6, 2018
Microbiome restoration biological drug product to be tested for safety and overall survival impact in…
MaaT PharmaOctober 12, 2018
Results from in silico analysis using MaaT Pharma’s data analysis platform, GutPrint, demonstrate therapeutic rationale…
MaaT PharmaSeptember 18, 2018
Une récente étude a démontré que la transplantation fécale serait particulièrement intéressante chez les personnes…
MaaT PharmaSeptember 5, 2018
La transplantation fécale, qui consiste à injecter un microbiote sain dans celui d'un patient malade,…
MaaT PharmaSeptember 4, 2018
MaaT Pharma receives world-wide exclusive license to technology co-developed with hematology and gastroenterology departments of…
MaaT PharmaJune 21, 2018
A first glimpse of the evolution of a complex ecosystem during in vitro fermentation can…
MaaT PharmaJune 20, 2018